KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Return on Invested Capital (2016 - 2025)

Edwards Lifesciences (EW) has 16 years of Return on Invested Capital data on record, last reported at 0.1% in Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 2.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, down 2.0%, while the annual FY2025 figure was 0.1%, 4.0% down from the prior year.
  • Return on Invested Capital reached 0.1% in Q4 2025 per EW's latest filing, down from 0.12% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.3% in Q2 2021 and bottomed at 0.1% in Q4 2025.
  • Average Return on Invested Capital over 5 years is 0.19%, with a median of 0.18% recorded in 2023.
  • The widest YoY moves for Return on Invested Capital: up 11bps in 2021, down -8bps in 2021.
  • A 5-year view of Return on Invested Capital shows it stood at 0.25% in 2021, then dropped by -17bps to 0.21% in 2022, then decreased by -13bps to 0.18% in 2023, then tumbled by -32bps to 0.12% in 2024, then dropped by -19bps to 0.1% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.1% in Q4 2025, 0.12% in Q3 2025, and 0.12% in Q2 2025.